已收盘 09-11 16:00:00 美东时间
-0.300
-1.71%
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 2026年9月10日,在中华医学会第三十次眼科学术大会启幕首日,华厦眼科与博士伦...
09-12 10:30
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Leerink Partners analyst Daniel Clark initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Outperform rating and announces Price Target of $24.
09-09 23:06
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从14美元升至14.5美元;HC Wainwright & Co.:维持Generate Biomedicines"买入"评级,目标价从25美元升至30美元
08-31 18:14
HC Wainwright & Co. analyst Yi Chen reiterates Bausch & Lomb (NYSE:BLCO) with a Buy and maintains $21 price target.
08-28 18:14
Bausch + Lomb (BLCO) said it will advance a dry eye drop into phase 3 development that is a combination of Xiidra (lifitegrast) and Miebo (perfluorohexyloctane). The study will test the combination dr...
08-25 05:19
Carl Icahn‘s latest portfolio update is notable less for what he bought than for what he didn’t. The billionaire activist investor made no new stock purchases during the second quarter, instead trimming positions in JetBlue Airways Corporation (NASDAQ:JBLU) and American Electric Power Company, Inc. ...
08-17 20:58
Bausch + Lomb press release (BLCO): Q2 Revenue of $1.39B. Reaffirming 2026 Guidance Bausch + Lomb reaffirms the full-year 2026 guidance it raised on July 29, 2026, including revenue of $5.440 bill...
08-07 01:24
LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"), today announced that its CEO, Thomas J. Appio, has been appoint...
08-06 19:04